Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Antiviral effects of Lactobacillus crispatus against HSV‐2 in mammalian cell lines

  • 2018-03
  • Journal of the Chinese Medical Association 81(3)
    • E. Mousavi
    • M. Makvandi
    • A. Teimoori
    • A. Ataei
    • S. Ghafari
    • A. Samarbaf-zadeh

Abstract

Background: Herpes simplex virus type 2 (HSV-2) infectious disease is one of the most common viral sexually transmitted diseases. As regards, vaginal lactobacilli play an important role in protecting host against the urogenital pathogens; here we assessed the potential antiviral activity of Lactobacillus crispatus against HSV-2 infection in vitro.

Methods: Both Vero and HeLa cell lines were treated by L. crispatus before, during and after HSV-2 infection. The pre-incubation assay was also performed for the evaluating of virus adsorption by L. crispatus. Virus titer reduction in each stage was determined by a plaque reduction assay.

Results: L. crispatus significantly decreased the infectivity of the HSV-2 in initial steps on both cell lines; however, no significant inhibition was ascertained during adsorption and multiplication process. The lactobacilli adhere on Vero cells two-fold stronger than HeLa and subsequently protect the Vero cells nearly 2.5 fold higher than HeLa cell against the virion. Co-incubation of HSV-2 with bacterial cells prior to virus inoculation significantly decreased the virus titer.

Conclusion: L. crispatus appears to inhibit the entry of the virus into cells by trapping HSV-2 particles. In addition, formation of L. crispatus microcolonies in the cell surface could block HSV-2 receptors and prevent viral entry to cells in initial infection steps.

Keywords: Antiviral activity; HSV-2; HeLa cell line; Lactobacillus crispatus.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus crispatus LV5 88Enhanced Cellular Protection Against HSV-2Beneficial
Moderate
Lactobacillus crispatus LV5 88Reduced HSV-2 InfectivityBeneficial
Moderate
Lactobacillus crispatus LV5 88Reduced HSV-2 Virus TiterBeneficial
Moderate
Lactobacillus crispatus LV5 88Reduced Viral EntryBeneficial
Moderate
Lactobacillus crispatus VPro 31Protection Against HSV-2 InfectionBeneficial
Moderate
Lactobacillus crispatus VPro 31Reduced HSV-2 InfectivityBeneficial
Moderate
Lactobacillus crispatus VPro 31Reduced Virus TiterBeneficial
Moderate
Back to top